Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Sales | 1,085.29 | 945.18 | 1,014.58 | 848.86 | 874.89 |
| Operating profit | 327.18 | 273.65 | 276.90 | 144.53 | 159.41 |
| Interest | 2.36 | 2.27 | 0.75 | 1.21 | 2.68 |
| Gross profit | 338.55 | 323.54 | 307.61 | 180.07 | 187.24 |
| EPS (Rs) | 17.42 | 16.81 | 16.78 | 9.28 | 9.64 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Other income | 13.73 | 52.16 | 31.46 | 36.75 | 30.51 |
| Stock adjustment | 31.01 | -28.16 | 34.40 | -6.03 | -46.15 |
| Raw material | 239.04 | 223.55 | 217.81 | 231.89 | 246.01 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 216.41 | 205.48 | 196.30 | 207.06 | 175.53 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 271.65 | 270.66 | 289.17 | 271.41 | 340.09 |
| Provisions made | - | - | - | - | - |
| Depreciation | 33.41 | 33.04 | 32.24 | 32.11 | 32.29 |
| Taxation | 84.99 | 78.14 | 63.33 | 30.75 | 30.99 |
| Net profit / loss | 220.15 | 212.36 | 212.04 | 117.21 | 123.96 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.27 | 25.27 | 25.27 | 25.27 | 25.71 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 30.15 | 28.95 | 27.29 | 17.03 | 18.22 |
| GPM (%) | 30.80 | 32.44 | 29.41 | 20.33 | 20.68 |
| NPM (%) | 20.03 | 21.29 | 20.27 | 13.23 | 13.69 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis